Tenax Therapeutics
TENX
16 hedge funds and large institutions have $373K invested in Tenax Therapeutics in 2023 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 5 closing their positions.
102% more capital invested
Capital invested by funds: $185K → $373K (+$188K)
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
14% more funds holding
Funds holding: 14 → 16 (+2)
0.04% more ownership
Funds ownership: 0.03% → 0.07% (+0.04%)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$102K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$55.8K |
| 3 |
Two Sigma Investments
New York
|
+$42.7K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$22.8K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$12.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$29K |
| 2 |
VF
Virtu Financial
New York
|
-$11K |
| 3 |
LPL Financial
San Diego,
California
|
-$5.98K |
| 4 |
APP
Avantax Planning Partners
Dubuque,
Iowa
|
-$2.99K |
| 5 |
Lido Advisors
Los Angeles,
California
|
-$2.99K |
TENX Hedge Fund Activity: Q4 2023 in Review
16 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q4 2023, worth a combined $373K — up 102% from $185K a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new TENX positions and 5 closed out — a net gain of 2 holders — while 3 added to existing stakes and 3 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $102K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $29K sold.
- 16 institutional investors held Tenax Therapeutics (TENX) as of Q4 2023, up from 14 in Q3 2023.
- Funds reported $373K of Tenax Therapeutics stock for Q4 2023, up 102% quarter-over-quarter.
- 7 funds opened new Tenax Therapeutics positions in Q4 2023 and 5 closed out, a net change of +2 holders.
- The largest Tenax Therapeutics buyer in Q4 2023 was Renaissance Technologies, an estimated $102K added.
- The largest Tenax Therapeutics seller in Q4 2023 was Two Sigma Securities, an estimated $29K sold.
Based on aggregated 13F filings for Q4 2023.